BVS Q3 2025 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$139M-0.2% YoY

Gross Profit

$93M67.0% margin

Operating Income

$12M8.7% margin

Net Income

$3M2.3% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

-6.1%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$702M

Total Liabilities

$494M

Stockholders' Equity

$166M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$139M	-0.2%
Gross Profit	$93M	$94M	-0.8%
Operating Income	$12M	$4M	+197.1%
Net Income	$3M	-$5M	+165.4%

Revenue Segments

U.S. Segment

$123M89%

International Segment

$15M11%

Geographic Segments

UNITED STATES

$123M89%

Non-US

$15M11%